Enveric Biosciences Inc vs Twist Bioscience Corp — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Twist Bioscience Corp is far larger — about 1245.2× Enveric Biosciences Inc's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | TWST | |
|---|---|---|
Market Cap | $6.20M | $7.72B |
Sector | Health | Health |
52-Week High | $17.40 | $124.88 |
52-Week Low | $1.27 | $24.16 |
Enterprise Value | $1.30M | $7.65B |
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →